|May 2002 · Vol. 14, No. 5
HRT treatment for osteoporosis challenged
In the January article, “SERMs: protection without worry?” Anthony Luciano, MD, states that the National Osteoporosis Foundation (NOF) “recommends hormone replacement therapy (HRT) as the first-line agent for the treatment and prevention of osteoporosis in the general population.”
It is important to note that the FDA has approved HRT for the prevention and management of osteoporosis, but not for treatment. NOF’s recommendations concur with these FDA indications.